EMDT’s series of interviews offers personal perspectives on the diverse and dynamic medical device technology sector. Here, we talk to Dr. Liu Daozhi, Senior Vice President for Business Development at MicroPort Medical in Shanghai.
Q: What is the first thing you do when you get to the office?
A: I decide on the issues that should be finished on this day, prioritising them based on their importance.
Q: If you were not taking this interview, what would you be doing?
A: I might be chairing a meeting with my management team, or participating in a conference call with some clients or reading some research or an industry review.
|Dr. Liu Daozhi, Senior Vice President for Business Development at MicroPort Medical in Shanghai, China|
Q: How did you get in the industry?
A: I got into the medical device industry more than 10 years ago because of the recommendation of a friend. Before joining MicroPort Medical, I was a professor of materials engineering at Tianjin University. I had known the chairman of this company for a long time, and he invited me to join the company while it was still a start up. I have accumulated expertise in the medtech field as I contributed to the growth of MicroPort. I witnessed MicroPort’s evolution into one of the leading medical device companies in China.
Q: What is the most rewarding part of your work?
A: The most rewarding part of my career is contributing to saving the lives of thousands of people and helping them to stay healthy by using our products and services.
Q: What is the most challenging part about your work?
A: Overcoming the challenges of a new position or new responsabilities that I am not familiar with. For example, launching a new business driven by a technology innovation or being involved in an M&A project that demands integration of existing and new businesses. I have faced these challenges many times during my career at MicroPort and have enjoyed successfully meeting them while improving my own competence and knowledge.
Q: Will your job be any different five years from now, and if so, how?
A: I can predict that I will improve my own abilities and gain experience from an international perspective. M&A and investment related to the medtech industry are new activities in China compared with the United States and European countries. China’s medical device industry has experienced impressive growth of more than 30% during the past five years; consequently, there will be an increasing number of M&As. I have high expectations that I will be involved in the whole process and obtain an international perspective and experience.
Q: What’s so great about your company’s technology?
A: MicroPort’s technology enables minimally invasive surgery for coronary disease as well as peripheral and cerebrovascular disease. We also are developing innovative technologies and products for the treatment of diabetes and orthopaedic disorders. I am very proud that we are able to provide so much new technology to save millions of patients from illness and improve their quality of life.
Q: What do you think is the most important medical device invention ever?
A: The drug-eluting stent and pacemaker are the most important medical device inventions ever.
Q: What should people give more attention to?
A: The unmet needs of patients, especially their demand for cost-effective medical technology.
Q: What is the most exciting development on the horizon?
A: The renal denervation treatment device, which will be the next blockbuster device.
Q: What do you want from your suppliers?
A: Top notch and high-quality raw materials, equipment and services.
Dr. Liu Daozhi is Senior Vice President for Business Development at MicroPort Medical in Shanghai, China. The company develops and manufactures cardiovascular devices, orthopaedic implants and related products for the treatment of a range of conditions. He can be contacted by phone at +86 21 3895 4600, ext. 220, or via email at firstname.lastname@example.org. Visit the company website at www.microport.com.cn.